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Backrgound: Preoperative Brain Natriuretic Peptide (BNP) levels may be predictive of major cardiac events (MACE) after major orthopaedic 
surgery (MOS).Their exact use is not established. The purpose of this study was to compare BNP to established preoperative cardiac risk scores as 
predictors of MACE after MOS.
Methods:  Patients >65 years old (n=173, 79.9±8 years old, 129 women - 45 men) submitted to urgent or elective MOS were included. Goldman, 
Detsky, Lee and Fleisher- Eagle (F/E) scores were assessed and serum BNP levels measured preoperatively. Spearman correlation coefficients 
between BNP and the abovementioned scores were calculated. Receiver operating curves (ROC) were constructed for the prediction of in-hospital 
MACE (defined as a composite of death, non fatal myocardial infarction, acute heart failure and pulmonary embolism).
Results: BNP significantly correlated with all the above validated cardiac risk scores (correlation coefficients were 0.485 for Goldman, 0.395 for 
Lee, 0.558 for Detsky, 0,447 for F/E with p<0.0001 for all correlations) During hospitalization 11 MACE were documented. The areas under the ROC 
curves (AUC(p)) for the prediction of MACE are for BNP 0.827 (0.0001)- Detsky 0.797 (0.001) -Goldman 0.717 (0.018)- F/E 0.736 (0.009) -Lee 
0.587 (0.336)
No significant differences (by z-statistic calculation) were found when the AUC of BNP was compared to the AUCs of Detsky, Goldman and F/E scores. 
Interestingly, a BNP cut-off point of 190 pg/mL was identified (sensitivity 72.7%, specificity of 77.2%).
Conclusions:  BNP is a simple biomarker predictive of MACE following MOS. Its potential complementary role to established clinical scores for 
preoperative risk assessment should be further investigated.
